CHLVPP chemotherapy involved-field irradiation Hodgkin disease favorable results acceptable toxicity Patients Hodgkin disease chemotherapy chlorambucil vinblastine procarbazine prednisone CHLVPP regimen limited involved-field radiation therapy treatment Hodgkin disease Nebraska Lymphoma Study Group patients Hodgkin disease previous radiation therapy regimen Complete remissions CRs patients total relapses overall failure-free survival good-prognosis patients ie Karnofsky performance status equal failure-free survival Toxicity regimen minimal neutropenic fevers patient population moderate alopecia nausea vomiting patients primary induction therapy Hodgkin disease CHLVPP effective regimen high patient acceptance profile 